Biotricity Inc (BTCY)

Healthcare | Medical Devices
Income Statement (Quarterly) 2025-06-30 2024-12-31 2024-09-30 2024-06-30
Revenue 3,873,993 3,619,108 3,266,846 3,201,743
Cost of Revenue 757,193 855,140 807,672 838,575
Gross Profit 3,116,800 2,763,968 2,459,174 2,363,168
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 2,138,692 2,381,734 2,248,864 2,966,119
Operating Expenses 2,834,855 2,932,950 2,766,846 3,480,014
Operating Income 281,945 -168,982 -307,672 -1,116,846
Interest Expense 1,003,826 1,140,666 1,091,963 1,913,401
Income Before Tax -671,977 -1,229,154 -1,561,768 -3,694,520
Income Tax Expense 0 89,392 91,261 0
Net Income -671,977 -1,229,154 -1,561,768 -3,694,520
Per Share
EPS -0.03 -0.05 -0.07 -0.26
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Revenue 13,790,294 12,063,345 9,639,057 7,650,269 3,384,767
Cost of Revenue 3,225,803 3,707,064 4,197,024 3,080,116 1,871,125
Gross Profit 10,564,491 8,356,281 5,442,033 4,570,153 1,513,642
Operating Expenses
R&D Expenses 0 0 0 0 0
SG&A Expenses 10,857,797 14,612,724 17,621,865 18,562,369 12,806,306
Operating Expenses 13,013,457 17,184,550 20,851,744 21,306,956 14,865,436
Operating Income -2,448,966 -8,828,269 -15,591,652 -17,877,325 -13,351,794
Interest Expense 5,201,854 5,191,723 2,582,618 10,569,593 2,481,155
Income Before Tax -8,421,179 -14,094,283 -18,658,143 -29,130,477 -15,491,176
Income Tax Expense 0 0 2,400,677 9,429,071 0
Net Income -8,421,179 -14,094,283 -18,658,143 -29,130,477 -15,491,176
Per Share
EPS -0.55 -1.66 -2.15 -3.85 -0.44
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Assets
Cash and Cash Equivalents 365,145 786,060 570,460 12,066,929
Short Term Investments 0 0 588,599 0
Net Receivables 2,718,762 1,805,111 1,224,137 2,412,958
Inventory 1,555,385 1,879,402 2,337,006 842,924
Total Current Assets 4,639,292 4,470,573 4,720,202 15,322,811
Property Plant Equipment 821,652 1,237,145 1,608,998 1,270,159
Goodwill and Intangibles 0 0 0 0
Total Assets 5,640,954 5,942,625 6,510,544 16,677,970
Liabilities
Account Payables 4,602,309 5,221,992 3,435,123 1,159,477
Short Term Debt 12,550,024 12,093,842 5,110,076 1,750,320
Total Current Liabilities 20,636,148 22,698,826 11,160,768 4,866,814
Long Term Debt 13,540,189 11,784,948 14,436,096 13,603,490
Total Liabilities 35,655,054 35,919,442 26,355,929 18,822,706
Shareholders Equity
Retained Earnings -139,441,785 -127,499,785 -112,570,825 -93,037,142
Total Shareholders Equity -30,014,100 -29,976,817 -19,845,385 -2,144,736
Balance Sheet (Annual) 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Assets
Cash and Cash Equivalents 365,145 786,060 570,460 12,066,929 2,201,562
Short Term Investments 0 0 588,599 0 0
Net Receivables 2,718,762 1,805,111 1,224,137 2,412,958 1,847,500
Inventory 1,555,385 1,879,402 2,337,006 842,924 272,493
Total Current Assets 4,639,292 4,470,573 4,720,202 15,322,811 4,321,555
Property Plant Equipment 821,652 1,237,145 1,608,998 1,270,159 66,120
Goodwill and Intangibles 0 0 0 0 0
Total Assets 5,640,954 5,942,625 6,510,544 16,677,970 4,438,033
Liabilities
Account Payables 4,602,309 5,221,992 3,435,123 1,159,477 1,041,385
Short Term Debt 12,550,024 12,093,842 5,110,076 1,750,320 4,336,275
Total Current Liabilities 20,636,148 22,698,826 11,160,768 4,866,814 10,490,255
Long Term Debt 13,540,189 11,784,948 14,436,096 13,603,490 370,900
Total Liabilities 35,655,054 35,919,442 26,355,929 18,822,706 11,271,197
Shareholders Equity
Retained Earnings -139,441,785 -127,499,785 -112,570,825 -93,037,142 -62,817,688
Total Shareholders Equity -30,014,100 -29,976,817 -19,845,385 -2,144,736 -6,833,164
Cash Flow Statement (Quarterly) 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Operating Activities
Net Income -8,421,179 -14,094,283 -18,658,143 -29,130,477
Depreciation & Amortization 5,953 2,172,920 5,953 2,308
Stock Based Compensation 1,461,698 1,025,930 647,631 913,613
Change in Working Capital 962,229 3,682,697 2,308,764 -117,583
Operating Cash Flow -2,380,177 -6,693,912 -13,547,935 -15,163,384
Investing Activities
Capital Expenditure -3 0 0 -29,767
Investments 0 0 0 -29,767
Investing Cash Flow 0 0 0 -29,767
Financing Activities
Debt Repayment 101,484 3,815,416 -3,831,440 -1,660,220
Common Stock Issued/Repurchased 125,227 119,285 -883,056 14,565,805
Dividends Paid -29,984 -18,016 -946,780 -966,110
Financing Cash Flow 1,929,259 6,741,685 2,001,603 25,168,230
Summary
Free Cash Flow -2,380,177 -6,693,912 -13,547,935 -15,193,151
Net Change in Cash -420,915 215,600 -11,496,469 9,865,367
Cash Flow Statement (Annual) 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Operating Activities
Net Income -8,421,179 -14,094,283 -18,658,143 -29,130,477 -15,491,176
Depreciation & Amortization 5,953 2,172,920 5,953 2,308 0
Stock Based Compensation 1,461,698 1,025,930 647,631 913,613 790,535
Change in Working Capital 962,229 3,682,697 2,308,764 -117,583 -627,902
Operating Cash Flow -2,380,177 -6,693,912 -13,547,935 -15,163,384 -11,080,831
Investing Activities
Capital Expenditure -3 0 0 -29,767 0
Investments 0 0 0 -29,767 0
Investing Cash Flow 0 0 0 -29,767 0
Financing Activities
Debt Repayment 101,484 3,815,416 -3,831,440 -1,660,220 -408,082
Common Stock Issued/Repurchased 125,227 119,285 -883,056 14,565,805 0
Dividends Paid -29,984 -18,016 -946,780 -966,110 -602,969
Financing Cash Flow 1,929,259 6,741,685 2,001,603 25,168,230 12,203,480
Summary
Free Cash Flow -2,380,177 -6,693,912 -13,547,935 -15,193,151 -11,080,831
Net Change in Cash -420,915 215,600 -11,496,469 9,865,367 1,251,714